The effect of chronic dosing and p53 status on the genotoxicity of pro-oxidant chemicals in vitro.


Journal

Mutagenesis
ISSN: 1464-3804
Titre abrégé: Mutagenesis
Pays: England
ID NLM: 8707812

Informations de publication

Date de publication:
31 12 2020
Historique:
received: 29 06 2020
accepted: 07 09 2020
pubmed: 2 12 2020
medline: 18 1 2022
entrez: 1 12 2020
Statut: ppublish

Résumé

In this study, we have studied the cytotoxicity and genotoxic potency of 3 pro-oxidants; H2O2, menadione and KBrO3 in different dosing scenarios, namely acute (1-day dosing) and chronic (5-days). For this purpose, relative population doubling (RPD%) and mononucleated micronucleus (MN) test were used. TK6 cells and NH32 were employed in in vitro experiments. In the study, the total acute dose was divided into 5 days for each prooxidant chemicals by dose fractionation (1/5th per day) method. Acute dosing was compared to chronic dosing. The oxidative stress caused by the exposure of cells with pro-oxidant chemicals to the cells was determined by an optimized 2',7'-dichlorofluorescein diacetate (DCFHDA) test method. The antioxidant levels of the cell lines were altered with buthionine sulfoxide (BSO) and N-acetyl cysteine (NAC), and the effect of antioxidant capacity on the MN formation in the cells was observed with this method. In the case of H2O2 and menadione, fractional dosing has been observed to result in lower toxicity and lower genotoxicity. But in the case of KBrO3, unlike the other 2 pro-oxidants, higher MN induction was observed with fractionated doses. DCFHDA test clearly demonstrated ROS induction with H2O2 and menadione but not with KBrO3. Unexpectedly, DCFHDA test demonstrated that KBrO3 did not cause an increase ROS levels in both acute and chronic dosing, suggesting an alternative ROS induction mechanism. It was also observed that, treatment with BSO and NAC, caused increasing and decreasing of MN fold change respectively, allowing further ROS specific mechanisms to be explored. Hence, dose fractionation expectedly caused less MN, cytotoxicity and ROS formation with H2O2 and menadione exposure, but not with KBrO3. This implies a unique mechanism of action for KBrO3 induced genotoxicity. Chronic dosing in vitro may be a valuable approach allowing better understanding of how chemicals damage DNA and pose human hazards.

Identifiants

pubmed: 33259605
pii: 6015768
doi: 10.1093/mutage/geaa024
doi:

Substances chimiques

Mutagens 0
Oxidants 0
Reactive Oxygen Species 0
Tumor Suppressor Protein p53 0
Vitamin K 3 723JX6CXY5
Hydrogen Peroxide BBX060AN9V
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-489

Subventions

Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/R001375/1
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Emrah Dural (E)

In vitro Toxicology Group, Institute of Life Science, College of Medicine, Swansea University, Swansea, U.K.
Sivas Cumhuriyet University, Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Sivas, Turkey.

Ume-Kulsoom Shah (UK)

In vitro Toxicology Group, Institute of Life Science, College of Medicine, Swansea University, Swansea, U.K.

Demi Pritchard (D)

In vitro Toxicology Group, Institute of Life Science, College of Medicine, Swansea University, Swansea, U.K.

Katherine Emma Chapman (KE)

In vitro Toxicology Group, Institute of Life Science, College of Medicine, Swansea University, Swansea, U.K.

Shareen Heather Doak (SH)

In vitro Toxicology Group, Institute of Life Science, College of Medicine, Swansea University, Swansea, U.K.

Gareth James Scott Jenkins (GJS)

In vitro Toxicology Group, Institute of Life Science, College of Medicine, Swansea University, Swansea, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH